Corticosteroids Decrease the Incidence and Activity of Choroidal Neovascularization in Patients with Punctuate Inner Choroidopathy or Multifocal Choroiditis.
Vienne-Jumeau A, Brézin AP, Seminel M, Ribeaudeau-Saindelle F, Bousquet E.
Ocul Immunol Inflamm. 2024 Jul;32(5):602-608. doi: 10.1080/09273948.2023.2181189. Epub 2023 Mar 3.
Punctate inner choroidopathy in common variable immunodeficiency associated with a pathogenic variant in the tumour necrosis factor receptor superfamily 13b (TNFRSF13B) gene - Case report and review of the literature.
Salih H, Wai KCK, McKee J, Chopra C.
Clin Immunol. 2023 Oct;255:109748. doi: 10.1016/j.clim.2023.109748. Epub 2023 Aug 29.
Ocular coherence tomographic and clinical characteristics in patients of punctuate inner choroidopathy associated with zonal outer retinopathy.
Chen SN, Hwang JF.
Ocul Immunol Inflamm. 2014 Aug;22(4):263-9. doi: 10.3109/09273948.2013.844264. Epub 2013 Dec 19.
Pregnancy-associated retinal diseases and their management.
Errera MH, Kohly RP, da Cruz L.
Surv Ophthalmol. 2013 Mar-Apr;58(2):127-42. doi: 10.1016/j.survophthal.2012.08.001.
[White dot syndrome].
Göbel W.
Ophthalmologe. 2008 Jan;105(1):91-108; quiz 109. doi: 10.1007/s00347-007-1687-6.
RPE disruption and hyper-transmission are early signs of secondary CNV with punctate inner choroidopathy in structure-OCT.
Chen Y, Chen Q, Li X, Li M.
BMC Ophthalmol. 2021 Dec 10;21(1):427. doi: 10.1186/s12886-021-02197-7.
Efficacy and safety of conbercept as a primary treatment for choroidal neovascularization secondary to punctate inner choroidopathy.
Peng Y, Zhang X, Mi L, Liu B, Zuo C, Li M, Wen F.
BMC Ophthalmol. 2017 Jun 12;17(1):87. doi: 10.1186/s12886-017-0481-8.
COMPARISON OF PRIMARY AND SECONDARY FORMS OF MULTIPLE EVANESCENT WHITE DOT SYNDROME.
Serrar Y, Cahuzac A, Gascon P, Langlois-Jacques C, Mauget-Faÿsse M, Wolff B, Sève P, Kodjikian L, Mathis T.
Retina. 2022 Dec 1;42(12):2368-2378. doi: 10.1097/IAE.0000000000003609.
In response to: Parodi MB, Iacono P, Zucchiatti I, et al. Choroidal Neovascularization Associated with Multiple Evanescent White Dot Syndrome Treated with Intravitreal Ranibizumab.
Mathis T, Kodjikian L.
Ocul Immunol Inflamm. 2018;26(4):612-613. doi: 10.1080/09273948.2017.1306086. Epub 2017 Apr 27.
White dot syndromes: a 20-year study of incidence, clinical features, and outcomes.
Abu-Yaghi NE, Hartono SP, Hodge DO, Pulido JS, Bakri SJ.
Ocul Immunol Inflamm. 2011 Dec;19(6):426-30. doi: 10.3109/09273948.2011.624287.
